ORGANIZING PNEUMONIA: AN ETIOLOGICAL DILEMMA IN PATIENTS ON RITUXIMAB FOR TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER

被引：0
|
作者：
Freeman, Howard
Zuckerman, Omry
O'Sullivan, Mary
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.3338
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：5626A / 5627A
页数：2
相关论文
共 50 条
  • [1] Outcome of repeated rituximab treatment in 81 patients with neuromyelitis optica spectrum disorder
    Kim, S. -H.
    Kim, W.
    Huh, S. -Y.
    Lee, S. J.
    Joung, A. -R.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 294 - 295
  • [2] Relapses shortly after rituximab treatment in neuromyelitis optica spectrum disorder
    Shi, Bingxin
    Zhao, Mangsuo
    Qiao, Liyan
    Huang, Fangjie
    Zhou, Shimei
    Wei, Yan
    Wang, Jing
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 54
  • [3] Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
    Demuth, Stanislas
    Collongues, Nicolas
    Audoin, Bertrand
    Ayrignac, Xavier
    Bourre, Bertrand
    Ciron, Jonathan
    Cohen, Mikael
    Deschamps, Romain
    Durand-Dubief, Francoise
    Maillart, Elisabeth
    Papeix, Caroline
    Ruet, Aurelie
    Zephir, Helene
    Marignier, Romain
    De Seze, Jerome
    NEUROLOGY, 2023, 101 (04) : E438 - E450
  • [4] Safety and efficacy of rituximab in neuromyelitis optica spectrum disorder
    Radaelli, M.
    Moiola, L.
    Privitera, D.
    Rodegher, M.
    Colombo, B.
    Barcella, V.
    Sangalli, F.
    Esposito, F.
    Comi, G.
    Martinelli, V.
    JOURNAL OF NEUROLOGY, 2011, 258 : 261 - 262
  • [5] Treatment patterns in patients with neuromyelitis optica spectrum disorder
    Mouchet, J.
    Spelman, T.
    Costantino, C.
    Kalincik, T.
    Nytrova, P.
    Shaygannejad, V.
    Patti, F.
    Alroughani, R.
    Terzi, M.
    Ozakbas, S.
    Turkoglu, R.
    Avasarala, J.
    Mccombe, P.
    Simo, M.
    Granella, F.
    Hor, J. Yung
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 480 - 481
  • [6] Nomogram for the prediction of relapse factors in patients with neuromyelitis optica spectrum disorder during rituximab treatment
    Huang, Yanning
    Wu, Lei
    Sun, Hui
    Gao, Sai
    Huang, Dehui
    Zhang, Xi
    NEUROLOGICAL SCIENCES, 2024, : 1807 - 1815
  • [7] Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder
    Giorgia Olivieri
    Viviana Nociti
    Raffaele Iorio
    Maria Chiara Stefanini
    Francesco Antonio Losavio
    Massimiliano Mirabella
    Paolo Mariotti
    Neurological Sciences, 2015, 36 : 2301 - 2302
  • [8] Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder
    Olivieri, Giorgia
    Nociti, Viviana
    Iorio, Raffaele
    Stefanini, Maria Chiara
    Losavio, Francesco Antonio
    Mirabella, Massimiliano
    Mariotti, Paolo
    NEUROLOGICAL SCIENCES, 2015, 36 (12) : 2301 - 2302
  • [9] A Case of Late-Onset Neuromyelitis Optica Spectrum Disorder Associated With Cryptogenic Organizing Pneumonia
    Ra, Seung Won
    Lim, Soyeoun
    Cha, Hee Jeong
    Kim, Sunyoung
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2022, 15
  • [10] A Case of Late-Onset Neuromyelitis Optica Spectrum Disorder Associated With Cryptogenic Organizing Pneumonia
    Ra, Seung Won
    Lim, Soyeoun
    Cha, Hee jeong
    Kim, Sunyoung
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2022, 15
12345